Lupin Limited LUPIN

Latest filings

• Routine15 28 Sept, 15:42 · BSE
  Intimation of Closure of Trading Window.
• Approval68 28 Sept, 09:11 · BSE
  Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension.
• Routine15 21 Sept, 16:25 · NSE
  Allotment of 24,111 Equity Shares under ESOP.
• Routine15 8 Sept, 16:34 · NSE
  Schedule of Institutional Investors Meets.
• Approval73 4 Sept, 17:38 · NSE
  A press release dated September 04, 2026, titled "Lupin Receives U.S
• Credit rating73 28 Aug, 09:43 · NSE
  ESG Rating by Crisil ESG Ratings and Analytics Ltd.
• General25 28 Aug, 09:41 · BSE
  Lupin Ltd - 500257 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- ESG Rating
• Routine15 25 Aug, 17:35 · BSE
  Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
• Routine15 25 Aug, 17:30 · NSE
  Allotment of 30967 Shares.
• General25 24 Aug, 18:45 · NSE
  ESG Rating by ESG Risk Assessments and Insights Limited.

Shown 15 minutes after publication. Real time with Pro.

Upcoming corporate actions

No announced actions in the next 60 days.